Bauerlein Alison — SEC insider filings
SEC reporting owner CIK 1596080. 41 insider filings on record with FilingPulse; latest filed 2026-10-05.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2020-09-02 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 34 legs across 24 filings — 345,927 shares, $7,214,713 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 69.
- Largest priced transaction: sale of 17,398 shares @ $53.83 ($936,496) in Inogen Inc, filed 2021-02-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inogen Inc (INGN) | EVP, Finance, & CFO | 17 | — | 19 legs · 111,749 sh · $6,029,249 | 58 |
| Sight Sciences, Inc. (SGHT) | Chief Operating Officer | 19 | — | 15 legs · 234,178 sh · $1,185,464 | 6 |
| Pear Therapeutics, Inc. (PEAR) | Director | 4 | — | — | 4 |
| GELESIS HOLDINGS, INC. (GLS) | Director | 1 | — | — | 1 |
Insider filings — Bauerlein Alison
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 25,260 @ $8.85 | EDGAR |
| 2026-07-06 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 24,184 @ $5.36 | EDGAR |
| 2026-05-19 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 12,728 @ $5.12 | EDGAR |
| 2026-04-03 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 25,874 @ $3.48 | EDGAR |
| 2026-02-05 | 4 | Sight Sciences, Inc. (SGHT) | Grant/award (A): 127,512 @ $0 | EDGAR |
| 2026-01-06 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 10,896 @ $7.82 · Sale (S): 9,647 @ $7.48 | EDGAR |
| 2025-11-13 | 4 | Sight Sciences, Inc. (SGHT) | Grant/award (A): 23,006 @ $0 | EDGAR |
| 2025-10-03 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 19,948 @ $3.30 | EDGAR |
| 2025-07-07 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 19,260 @ $4.10 | EDGAR |
| 2025-05-21 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 13,066 @ $3.48 | EDGAR |
| 2025-04-03 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 19,397 @ $2.31 | EDGAR |
| 2025-03-13 | 4 | Sight Sciences, Inc. (SGHT) | Grant/award (A): 286,738 @ $0 | EDGAR |
| 2025-01-06 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 10,102 @ $3.52 | EDGAR |
| 2024-10-03 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 10,130 @ $6.08 | EDGAR |
| 2024-07-03 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 10,497 @ $6.21 | EDGAR |
| 2024-05-20 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 13,066 @ $5.42 | EDGAR |
| 2024-04-04 | 4 | Sight Sciences, Inc. (SGHT) | Sale (S): 10,123 @ $5.08 | EDGAR |
| 2024-02-16 | 4 | Sight Sciences, Inc. (SGHT) | Grant/award (A): 315,421 @ $0 | EDGAR |
| 2023-05-11 | 4 | Sight Sciences, Inc. (SGHT) | Grant/award (A): 103,000 @ $0 · Grant/award (A): 71,800 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Pear Therapeutics, Inc. (PEAR) | Grant/award (A): 71,428 @ $0 | EDGAR |
| 2022-06-16 | 4 | Pear Therapeutics, Inc. (PEAR) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | GELESIS HOLDINGS, INC. (GLS) | Grant/award (A): 51,095 | EDGAR |
| 2021-12-10 | 4 | Pear Therapeutics, Inc. (PEAR) | Grant/award (A): 115 (derivative) @ $0 | EDGAR |
| 2021-12-07 | 4 | Pear Therapeutics, Inc. (PEAR) | Grant/award (A): 70,560 (derivative) @ $0 | EDGAR |
| 2021-12-03 | 4/A | Inogen Inc (INGN) | Option exercise (M): 8,702 @ $16.62 · Sale (S): 4,449 @ $39.44 · Sale (S): 1,904 @ $40.42 · Sale (S): 2,349 @ $41.33 · Option exercise (M): 8,702 (derivative) @ $0 | EDGAR |
| 2021-12-03 | 4 | Inogen Inc (INGN) | Option exercise (M): 546 @ $0 · Tax withholding (F): 490 @ $29.66 · Option exercise (M): 546 (derivative) @ $0 | EDGAR |
| 2021-09-03 | 4/A | Inogen Inc (INGN) | Option exercise (M): 252 @ $0 · Option exercise (M): 546 @ $0 · Tax withholding (F): 614 @ $60.34 · Option exercise (M): 252 (derivative) @ $0 · Option exercise (M): 546 (derivative) @ $0 | EDGAR |
| 2021-09-03 | 4 | Inogen Inc (INGN) | Option exercise (M): 253 @ $0 · Option exercise (M): 546 @ $0 · Tax withholding (F): 616 @ $60.57 · Option exercise (M): 253 (derivative) @ $0 · Option exercise (M): 546 (derivative) @ $0 | EDGAR |
| 2021-08-03 | 4 | Inogen Inc (INGN) | Option exercise (M): 8,235 @ $38.54 · Sale (S): 8,235 @ $80.01 · Option exercise (M): 1,397 @ $38.54 · Sale (S): 1,397 @ $80.33 · Option exercise (M): 8,235 (derivative) @ $0 · Option exercise (M): 1,397 (derivative) @ $0 | EDGAR |
| 2021-07-29 | 4 | Inogen Inc (INGN) | Option exercise (M): 9,632 @ $38.54 · Sale (S): 9,632 @ $75.02 · Option exercise (M): 9,632 (derivative) @ $0 | EDGAR |
| 2021-06-03 | 4 | Inogen Inc (INGN) | Option exercise (M): 252 @ $0 · Option exercise (M): 546 @ $0 · Tax withholding (F): 343 @ $60.34 · Option exercise (M): 252 (derivative) @ $0 · Option exercise (M): 546 (derivative) @ $0 | EDGAR |
| 2021-04-15 | 4 | Inogen Inc (INGN) | Option exercise (M): 1,200 @ $38.54 · Sale (S): 1,200 @ $60.00 · Option exercise (M): 1,641 @ $38.54 · Sale (S): 1,641 @ $60.14 · Option exercise (M): 1,200 (derivative) @ $0 · Option exercise (M): 1,641 (derivative) @ $0 | EDGAR |
| 2021-03-16 | 4 | Inogen Inc (INGN) | Option exercise (M): 18,098 @ $16.62 · Sale (S): 11,586 @ $52.01 · Sale (S): 6,512 @ $52.61 · Option exercise (M): 18,098 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Inogen Inc (INGN) | Option exercise (M): 253 @ $0 · Option exercise (M): 2,184 @ $0 · Tax withholding (F): 1,428 @ $53.14 · Option exercise (M): 253 (derivative) @ $0 · Option exercise (M): 2,184 (derivative) @ $0 · Grant/award (A): 12,231 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Inogen Inc (INGN) | Option exercise (M): 18,098 @ $16.62 · Sale (S): 17,398 @ $53.83 · Sale (S): 700 @ $55.19 · Option exercise (M): 18,098 (derivative) @ $0 | EDGAR |
| 2021-02-11 | 4 | Inogen Inc (INGN) | Option exercise (M): 8,973 @ $0.81 · Sale (S): 8,973 @ $55.06 · Option exercise (M): 8,973 (derivative) @ $0 | EDGAR |
| 2021-01-28 | 4 | Inogen Inc (INGN) | Option exercise (M): 8,973 @ $0.81 · Sale (S): 8,973 @ $50.04 · Option exercise (M): 8,973 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | Inogen Inc (INGN) | Option exercise (M): 18,098 @ $16.62 · Sale (S): 15,966 @ $44.28 · Sale (S): 2,132 @ $44.83 · Option exercise (M): 18,098 (derivative) @ $0 | EDGAR |
| 2020-12-16 | 4 | Inogen Inc (INGN) | Option exercise (M): 8,702 @ $16.62 · Sale (S): 4,449 @ $39.44 · Sale (S): 1,904 @ $40.42 · Sale (S): 2,349 @ $41.33 · Option exercise (M): 8,702 (derivative) @ $0 | EDGAR |
| 2020-12-02 | 4 | Inogen Inc (INGN) | Grant/award (A): 253 @ $35.28 · Tax withholding (F): 126 @ $35.28 · Tax withholding (F): 102 @ $35.28 · Tax withholding (F): 117 @ $35.28 · Option exercise (M): 253 (derivative) @ $0 | EDGAR |
| 2020-09-02 | 4 | Inogen Inc (INGN) | Grant/award (A): 252 @ $0 · Tax withholding (F): 125 @ $28.94 · Tax withholding (F): 102 @ $28.94 · Tax withholding (F): 117 @ $28.94 · Option exercise (M): 252 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1596080 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs